Tailored kidney cancer trial vaccine shows recurrence-free survival
HQ Team February 6, 2025: A phase I clinical trial has shown that personalized cancer vaccines targeting driver mutations can lead to 100%.
Drugs
Medical
Drugs
Health
Medical
Supernus’ injection to treat advanced Parkinson’s gets US regulator’s nod
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Drugs
Health
Medical
Staff of USAID placed on leave, overseas missions may shut down
All the US Agency for International Development (USAID) direct hire personnel have been placed on administrative leave globally.
Drugs
Health
Medical
First vaccine efficacy trial for Sudan Ebola during an outbreak starts in Uganda
The world’s first-ever clinical efficacy trial of a vaccine for Ebola disease arising out of the Sudan virus has started in Uganda, the.
Drugs
Health
Medical
WHO director-general rebuts US criticism, plans to cut budget
Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US government’s accusations against the global.
Drugs
Health
Medical
Global researchers complete world’s first synthetic yeast genome project
Global researchers, led by Australia’s Macquarie University, in a bid to re-engineer life in a laboratory, have completed the world’s first synthetic yeast.
Drugs
Research
Heavy cannabis use reduces brain activity during memory tasks
Bharti Jayshankar February 1, 2025: A study published in JAMA Network Open reveals that heavy cannabis use may impair brain function during critical.
Drugs
Health
Research
Cambridge researchers making brain implants to treat Parkinson’s
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Drugs
Health
Medical
Vertex’s non-opioid painkiller receives approval from US drug regulator
Vertex Pharmaceuticals Inc.’s non-opioid analgesic to treat moderate to severe acute pain in adults got approval from the US drug regulator.
Drugs
Health
Medical
UK’s NHS to provide gene therapy that may cure sickle cell disease in adults
Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to.